Synthetic Biologics, Inc. Uncategorized Contracts & Agreements

37 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Description of Securities of Theriva Biologics, Inc
Synthetic Biologics, Inc.
2024
Description of Securities of Theriva Biologics, Inc
Synthetic Biologics, Inc.
Biotechnology
2023
Technology Transfer Agreement between Bellvitge Biomedical Research Institute and VCN Biosciences S.L. dated August 31, 2010
Synthetic Biologics, Inc.
Biotechnology
2022
Description of Securities of Synthetic Biologics, Inc
Synthetic Biologics, Inc.
Biotechnology
2022
DESCRIPTION OF SECURITIES REGISTERED PURSUANT TO SECTION 12OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED
Synthetic Biologics, Inc.
Biotechnology
2021
Description of Securities
Synthetic Biologics, Inc.
Biotechnology
2020
Clinical Trial Agreement between Washington University School of Medicine in St. Louis and Synthetic Biologics, Inc. dated August 7, 2019
Synthetic Biologics, Inc.
Biotechnology
2019
Fifth Amendment dated August 22, 2017 to Sponsored Research Agreement dated December 19, 2012 between Synthetic Biologics, Inc. and The University of Texas at Austin
Synthetic Biologics, Inc.
Biotechnology
2018
Exhibit B
Synthetic Biologics, Inc.
Biotechnology
2016
Exhibit A
Synthetic Biologics, Inc.
Biotechnology
2016
FORM OF STOCKOPTION GRANT NOTICE
Synthetic Biologics, Inc.
Biotechnology
MI
2015
THIRD AMENDMENT TO EXCLUSIVE LICENSEAGREEMENT
Synthetic Biologics, Inc.
Biotechnology
2015
SECOND AMENDMENT TO REGISTRATION RIGHTSAGREEMENT
Synthetic Biologics, Inc.
Biotechnology
2015
AMENDMENT TO CLINICAL TRIAL AGREEMENT
Synthetic Biologics, Inc.
Biotechnology
2015
CLINICAL TRIAL AGREEMENT
Synthetic Biologics, Inc.
Biotechnology
CA
2015
STOCKPURCHASE AGREEMENT
Synthetic Biologics, Inc.
Biotechnology
CA
2013
STOCKPURCHASE AGREEMENT
Synthetic Biologics, Inc.
Biotechnology
CA
2013
EXCLUSIVE OPTION AGREEMENT
Synthetic Biologics, Inc.
Biotechnology
CA
2013
FOURTH AMENDMENT TO EXCLUSIVE LICENSEAGREEMENT UC Agreement Control No. 2006-04-0026
Synthetic Biologics, Inc.
Biotechnology
2013
THIRD AMENDMENT TO EXCLUSIVE LICENSEAGREEMENT UC Agreement Control No. 2006-04-0026
Synthetic Biologics, Inc.
Biotechnology
2013
First Amendment to theLicense Agreement Between The Regents of the University of California and General Fiber, Inc. UC Agreement Control No. 2006-04-0026
Synthetic Biologics, Inc.
Biotechnology
2013
SPONSORED RESEARCH AGREEMENT NO. UTA12-000950
Synthetic Biologics, Inc.
Biotechnology
2012
PATENT LICENSEAGREEMENT AGT. No.PM1300101
Synthetic Biologics, Inc.
Biotechnology
TX
2012
FIRST AMENDMENT TO REGISTRATION RIGHTSAGREEMENT
Synthetic Biologics, Inc.
Biotechnology
2012
EXECUTIONVERSION SECURITIESPURCHASE AGREEMENT
Synthetic Biologics, Inc.
Biotechnology
NY
2011
Very truly yours, Adeona Pharmaceuticals, Inc. By: Name:James S. Kuo, M.D., M.B.A. Title:Chairman and CEO Chardan Capital Markets, LLC By: Name: Title:
Synthetic Biologics, Inc.
Biotechnology
NY
2011
[Signature Page Follows]
Synthetic Biologics, Inc.
Biotechnology
NY
2010
Re:License agreement between Pipex Therapeutics, Inc. and Meda AB
Synthetic Biologics, Inc.
Biotechnology
2010
SUBLICENSE AGREEMENT BETWEEN MEDA AB AND PIPEX THERAPEUTICS, INC. May 6, 2010
Synthetic Biologics, Inc.
Biotechnology
MA
2010
Consent in Lieu of Special Meeting of the Board of Directors of Adeona Pharmaceuticals, Inc.
Synthetic Biologics, Inc.
Biotechnology
2009
SECOND AMENDMENT TO
Synthetic Biologics, Inc.
Biotechnology
2009
AMENDMENT
Synthetic Biologics, Inc.
Biotechnology
2009
EMPLOYMENTAGREEMENT
Synthetic Biologics, Inc.
Biotechnology
2009
Exhibit10.1 STOCKPURCHASE AGREEMENT
Synthetic Biologics, Inc.
Biotechnology
2009
AGREEMENTBY AND BETWEEN ACCREDITEDVENTURE CAPITAL, LLC AND ADEONAPHARMACEUTICALS, INC. DATEDJANUARY 14, 2009
Synthetic Biologics, Inc.
2009
Departure of directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
Synthetic Biologics, Inc.
Biotechnology
2009
Departure of directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
Synthetic Biologics, Inc.
2009